In this study, we found that the PD-L1 antibody treatment induced a similar tumor growth delay, with respect to the control groups, when treating either EMT-6 or EMT-6/CDDP primary tumors (Fig. 4a,b). The gene discussed is CD274; the disease is neoplasm.